Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.

Rahman HT, Yeh S, Bergstrom CS.

J Ocul Pharmacol Ther. 2013 Apr;29(3):360-2. doi: 10.1089/jop.2011.0178. Epub 2012 Oct 12.

PMID:
23061416
2.

Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment.

Wu PC, Lai CH, Chen CL, Kuo CN.

J Ocul Pharmacol Ther. 2012 Feb;28(1):59-64. doi: 10.1089/jop.2011.0070. Epub 2011 Oct 12.

PMID:
21992557
3.

Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.

Kim M, Lee P, Kim Y, Yu SY, Kwak HW.

Ophthalmologica. 2011;226(3):138-44. doi: 10.1159/000330045. Epub 2011 Aug 3.

PMID:
21822008
4.

Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.

Rahimy E, Sarraf D.

Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr;44(2):187-9. doi: 10.3928/23258160-20130212-02. Epub 2013 Feb 19.

PMID:
23421925
5.

Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab.

Baskin DE, Garg SJ.

Can J Ophthalmol. 2011 Apr;46(2):200-1. doi: 10.3129/i11-001. No abstract available.

PMID:
21708093
6.

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Apr;123(4):858-64. doi: 10.1016/j.ophtha.2015.11.030. Epub 2016 Jan 8.

7.

Bevacizumab in inflammatory eye disease.

Lott MN, Schiffman JC, Davis JL.

Am J Ophthalmol. 2009 Nov;148(5):711-717.e2. doi: 10.1016/j.ajo.2009.06.010. Epub 2009 Aug 5.

8.

Intravitreal bevacizumab for treatment of uveitic macular edema.

Cordero Coma M, Sobrin L, Onal S, Christen W, Foster CS.

Ophthalmology. 2007 Aug;114(8):1574-1579.e1. Epub 2007 Mar 23.

PMID:
17363060
9.

POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.

Dwivedi R, Tiroumal S.

Retin Cases Brief Rep. 2016 Oct 4. [Epub ahead of print]

PMID:
27749791
10.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
11.

Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome.

Demirel S, Batioğlu F, Özmert E.

J Ocul Pharmacol Ther. 2012 Dec;28(6):636-9. doi: 10.1089/jop.2012.0032. Epub 2012 Jun 25.

PMID:
22731243
12.

Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.

Shimura M, Yasuda K, Yasuda M, Nakazawa T.

Retina. 2013 Apr;33(4):740-7. doi: 10.1097/IAE.0b013e31826b6763.

PMID:
23222391
13.

Correlation of fundus autofluorescence with spectral-domain optical coherence tomography and vision in diabetic macular edema.

Chung H, Park B, Shin HJ, Kim HC.

Ophthalmology. 2012 May;119(5):1056-65. doi: 10.1016/j.ophtha.2011.11.018. Epub 2012 Feb 18.

PMID:
22342014
14.

Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection.

Al Faran A, Mousa A, Al Shamsi H, Al Gaeed A, Ghazi NG.

Retina. 2014 Jun;34(6):1208-15. doi: 10.1097/IAE.0000000000000059.

PMID:
24368308
15.

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Mackensen F, Heinz C, Becker MD, Heiligenhaus A.

Retina. 2008 Jan;28(1):41-5. doi: 10.1097/IAE.0b013e318156db75.

PMID:
18185136
16.

Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.

Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L; Pan-American Collaborative Retina Study Group.

Ophthalmology. 2009 Aug;116(8):1481-7, 1487.e1. doi: 10.1016/j.ophtha.2009.04.006. Epub 2009 Jul 9.

PMID:
19545901
17.

Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series.

Subrayan V, Khaw KW, Peyman M, Koay AC, Tajunisah I.

Ophthalmologica. 2013;229(4):208-11. doi: 10.1159/000348630. Epub 2013 Mar 26.

PMID:
23548379
18.

[Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].

Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.

J Fr Ophtalmol. 2011 Jun;34(6):376-81. doi: 10.1016/j.jfo.2011.03.004. Epub 2011 May 7. French.

19.

[Treatment of cystoid macular edema with bevacizumab in course of Irvine-Gass syndrome].

Izdebski B, Michalewska Z, Dziegielewski K, Nawrocki J, Odrobina D.

Klin Oczna. 2013;115(1):61-4. Polish.

PMID:
23882744
20.

The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.

Bakri SJ, Larson TA.

Semin Ophthalmol. 2015 Jul;30(4):276-80. doi: 10.3109/08820538.2013.847110. Epub 2013 Nov 19.

PMID:
24251435

Supplemental Content

Support Center